Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | NQO1 | P15559 | 6/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | TP53 | P04637 | 1/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.51 |
| ▸ | PCSK7 | Q16549 | 1/20 | 0.51 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15541690 | 1.00 | KDM4E (0.53) | KDM4ENQO1ALDH1A1CYP2C9MEN1 | |
| SCHEMBL15542047 | 0.88 | KDM4E (0.49) | KDM4ENQO1ALDH1A1CYP2C9MEN1 | |
| SCHEMBL6695228 | 0.80 | KDM4E (0.59) | KDM4ENQO1ALDH1A1CYP2C9MEN1 | |
| SCHEMBL16863152 | 0.78 | KDM4E (0.53) | KDM4EALDH1A1CYP2C9MEN1KMT2A | |
| SCHEMBL11766676 | 0.75 | MAPT (0.59) | KDM4ENQO1ALDH1A1CYP2C9MEN1 | |
| SCHEMBL11766670 | 0.75 | MAPT (0.59) | KDM4ENQO1ALDH1A1CYP2C9MEN1 | |
| SCHEMBL29379994 | 0.74 | KDM4E (0.69) | KDM4ENQO1ALDH1A1CYP2C9MEN1 | |
| SCHEMBL7737431 | 0.74 | KDM4E (0.69) | KDM4ENQO1ALDH1A1CYP2C9MEN1 | |
| SCHEMBL29872 | 0.74 | KDM4E (0.69) | KDM4ENQO1ALDH1A1CYP2C9MEN1 | |
| SCHEMBL30129469 | 0.74 | ALDH1A1 (0.37) | KDM4ENQO1ALDH1A1CYP2C9MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220296627-A1 | Cytidine Derivatives and Methods of Forming Cytidine Derivatives | Aenorasis Commercial Company of Pharmaceutical and Medical Products and Machines Societe Anonyme (GR) | 2022-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220296627-A1 | Cytidine Derivatives and Methods of Forming Cytidine Derivatives | DCTD, CDA, DCK | KDM4E 3844/4885NQO1 1682/4885ALDH1A1 2245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.